Excludes

  1. Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89)

    Type 2autoimmune disease (systemic) NOS (M35.9)

    Type 2certain conditions originating in the perinatal period (P00-P96)

    Type 2complications of pregnancy, childbirth and the puerperium (O00-O9A)

    Type 2congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)

    Type 2endocrine, nutritional and metabolic diseases (E00-E88)

    Type 2human immunodeficiency virus [HIV] disease (B20)

    Type 2injury, poisoning and certain other consequences of external causes (S00-T88)

    Type 2neoplasms (C00-D49)

    Type 2symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)

  2. Coagulation defects, purpura and other hemorrhagic conditions (D65-D69)
  3. Other coagulation defects (D68)

    Type 1abnormal coagulation profile NOS (R79.1)

    Type 2coagulation defects complicating abortion or ectopic or molar pregnancy (O00-O07, O08.1)

    Type 2coagulation defects complicating pregnancy, childbirth and the puerperium (O45.0, O46.0, O67.0, O72.3)

  4. Primary thrombophilia (D68.5)

    Type 1antiphospholipid syndrome (D68.61)

    Type 1lupus anticoagulant (D68.62)

    Type 1secondary activated protein C resistance (D68.69)

    Type 1secondary antiphospholipid antibody syndrome (D68.69)

    Type 1secondary lupus anticoagulant with hypercoagulable state (D68.69)

    Type 1secondary systemic lupus erythematosus [SLE] inhibitor with hypercoagulable state (D68.69)

    Type 1systemic lupus erythematosus [SLE] inhibitor finding without diagnosis (R76.0)

    Type 1systemic lupus erythematosus [SLE] inhibitor with hemorrhagic disorder (D68.312)

    Type 1thrombotic thrombocytopenic purpura (M31.19)

  5. Activated protein C resistance (D68.51)